Neuroscience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neuroscience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scott_jiminez who started this subject	1/2/2003 8:01:08 AM
From: scott_jiminez	Read Replies (1) of 278

Anti-alpha 4 integrin shows impressive promise for MS by attenuating appearance of lesions. content.nejm.org I've always felt that if a directed diminution of lymphocyte/macrophage migration to the brain during neurologic pathology (auto-immune or not) can be achieved, then a significant reduction of disease phenomenology will follow. Such an approach would also substantially mitigate microglial activation as well and this result alone would likely produce the most impressive improvements. The fact that interfering with lymphocyte adhesion produced such dramatic improvement in new plaque development (though, importantly, symptomology data was not reported) strongly suggests this approach has compelling legs.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next